相似文献
1
Does the Liver Provide Immunosuppressive Advantage?肝脏是否具有免疫抑制优势？
Clin Liver Dis (Hoboken). 2019 Jul 2;13(6):180-183. doi: 10.1002/cld.817. eCollection 2019 Jun.
2
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation.
Transplantation. 1995 May 27;59(10):1384-8. doi: 10.1097/00007890-199505270-00004.
3
Immunological advantage on small bowel graft induced by simultaneously transplanted liver in porcine auxiliary liver/small bowel transplantation.猪辅助性肝/小肠移植中同时移植肝脏对小肠移植物的免疫优势。
Transplant Proc. 2006 Dec;38(10):3251-2. doi: 10.1016/j.transproceed.2006.10.100.
4
Effect of long-term immunosuppressive therapy on native rat liver morphology and hepatocyte- apoptosis.长期免疫抑制治疗对大鼠原生肝脏形态及肝细胞凋亡的影响
Transpl Immunol. 2018 Oct;50:1-7. doi: 10.1016/j.trim.2018.05.001. Epub 2018 May 16.
5
Immunosuppressive Medication Adherence in Liver Transplant Recipients.肝移植受者的免疫抑制药物依从性
Transplant Proc. 2016 May;48(4):1198-201. doi: 10.1016/j.transproceed.2015.12.097.
6
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.一种新型免疫抑制药物布喹那钠对大鼠心脏、肝脏和肾脏同种异体移植排斥反应的影响。
Transplantation. 1992 Feb;53(2):303-8. doi: 10.1097/00007890-199202010-00009.
7
Assessment of readiness for clinical decision support to aid laboratory monitoring of immunosuppressive care at U.S. liver transplant centers.美国肝脏移植中心对临床决策支持以辅助免疫抑制治疗实验室监测的准备情况评估。
Appl Clin Inform. 2014 Dec 17;5(4):988-1004. doi: 10.4338/ACI-2014-08-RA-0060. eCollection 2014.
8
Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation.等待肝移植的肝硬化患者外周血单个核细胞对免疫抑制药物的敏感性增加。
Cell Transplant. 2006;15(10):885-91. doi: 10.3727/000000006783981314.
9
Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study.
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):661-7. doi: 10.1002/pds.3964. Epub 2016 Jan 22.
10
[Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis].[心肌炎和扩张型心肌病的免疫抑制治疗——批判性分析]
Z Kardiol. 1989 Jun;78(6):349-59.
引用本文的文献
1
Liver metastasis and resistance to immunotherapy in microsatellite stable colorectal cancer. A literature review.微卫星稳定型结直肠癌中的肝转移与免疫治疗耐药性：文献综述
Ecancermedicalscience. 2024 Sep 18;18:1771. doi: 10.3332/ecancer.2024.1771. eCollection 2024.
2
Immunology of simultaneous liver and kidney transplants with identification and prevention of rejection.肝肾联合移植的免疫学：排斥反应的识别与预防
Front Transplant. 2022 Nov 1;1:991546. doi: 10.3389/frtra.2022.991546. eCollection 2022.
3
Basics and Art of Immunosuppression in Liver Transplantation.肝移植中的免疫抑制基础与艺术
J Clin Exp Hepatol. 2024 May-Jun;14(3):101345. doi: 10.1016/j.jceh.2024.101345. Epub 2024 Jan 24.
4
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors.抗生素使用与免疫检查点抑制剂治疗 HCC 患者结局的关系。
Front Immunol. 2022 Aug 17;13:956533. doi: 10.3389/fimmu.2022.956533. eCollection 2022.
5
Pancreatic cancer among solid organ transplant recipients in the United States.美国实体器官移植受者中的胰腺癌。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3325-3333. doi: 10.1007/s00432-022-04227-3. Epub 2022 Aug 6.
6
Impact of COVID-19 Infection on Liver Transplant Recipients: Does It Make Any Difference?2019冠状病毒病感染对肝移植受者的影响：有何不同吗？
Cureus. 2022 Feb 28;14(2):e22687. doi: 10.7759/cureus.22687. eCollection 2022 Feb.
7
T Cell-Mediated Immune Responses to AAV and AAV Vectors.T 细胞介导的对 AAV 和 AAV 载体的免疫反应。
Front Immunol. 2021 Apr 13;12:666666. doi: 10.3389/fimmu.2021.666666. eCollection 2021.
8
Identification of peripheral CD154 T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.鉴定外周血 CD154T 细胞和 HLA-DRB1 作为成人肝移植受者急性细胞排斥反应的生物标志物。
Clin Exp Immunol. 2021 Feb;203(2):315-328. doi: 10.1111/cei.13533. Epub 2020 Oct 29.
本文引用的文献
1
Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.供者特异性低反应性在肝-肾联合移植受者中于第 1 年后出现。
Kidney Int. 2018 Jun;93(6):1465-1474. doi: 10.1016/j.kint.2018.01.022. Epub 2018 Apr 12.
2
Tolerance in clinical liver transplantation.临床肝移植中的耐受性
Hum Immunol. 2018 May;79(5):283-287. doi: 10.1016/j.humimm.2017.10.007. Epub 2017 Oct 18.
3
Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation.肾移植和肝移植同期与单独肾移植后肾脏移植物的独特分子变化。
Kidney Int. 2017 May;91(5):1193-1202. doi: 10.1016/j.kint.2016.12.016. Epub 2017 Feb 21.
4
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.急性排斥反应增加近期肝移植受者移植物失功和死亡风险。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):584-593.e2. doi: 10.1016/j.cgh.2016.07.035. Epub 2016 Aug 25.
5
Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.肝移植受者的肾脏保护：美国移植学会肝脏与肠道实践社区基于实践的建议
Am J Transplant. 2016 Sep;16(9):2532-44. doi: 10.1111/ajt.13765. Epub 2016 Apr 22.
6
Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation.在肝肾联合移植后，肾脏的慢性细胞和抗体介导的损伤减少。
Kidney Int. 2016 Apr;89(4):909-17. doi: 10.1016/j.kint.2015.10.016. Epub 2016 Jan 23.
7
Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.活体与尸体供肝移植受者体内的供者特异性 HLA 抗体
Am J Transplant. 2016 Aug;16(8):2437-44. doi: 10.1111/ajt.13757. Epub 2016 Mar 23.
8
Incidence and impact of rejection following simultaneous liver-kidney transplantation.肝-肾联合移植后排斥反应的发生率和影响。
J Hepatol. 2015 Feb;62(2):340-5. doi: 10.1016/j.jhep.2014.08.037. Epub 2014 Sep 6.
9
The role of donor-specific HLA alloantibodies in liver transplantation.供者特异性 HLA 同种抗体在肝移植中的作用。
Am J Transplant. 2014 Apr;14(4):779-87. doi: 10.1111/ajt.12667. Epub 2014 Mar 1.
10
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.在肝移植受者中，新产生的供体特异性 HLA 抗体可降低患者和移植物的存活率。
Am J Transplant. 2013 Jun;13(6):1541-8. doi: 10.1002/ajt.12212.
Zotero 插件